Cytek Biosciences, Inc. CTKB Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s operating income?
- Cytek Biosciences, Inc. (CTKB) reported operating income of -$18.46M in Q1 2026.
- How has Cytek Biosciences, Inc.'s operating income changed year-over-year?
- Cytek Biosciences, Inc.'s operating income decreased by 23.3% year-over-year, from -$14.98M to -$18.46M.
- What is the long-term trend for Cytek Biosciences, Inc.'s operating income?
- Over 3 years (2021 to 2025), Cytek Biosciences, Inc.'s operating income has grown at a 64.0% compound annual growth rate (CAGR), from $9.16M to -$40.39M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.